Vivet Therapeutics SAS
Beat Steffen - Director
Gene Therapy
Paris, France
Vivet Therapeutics SAS focuses on the discovery and clinical development of gene therapy and protein replacement therapy for inherited metabolic liver diseases.
It looks like you are using an older version of Internet Explorer which is not supported. We advise that you update your browser to the latest version of Microsoft Edge, or consider using other browsers such as Chrome, Firefox or Safari.